Literature DB >> 7097302

Arginine vasopressin levels in cerebrospinal fluid in neurological disease.

A C Reid, J J Morton.   

Abstract

Levels of arginine vasopressin have been measured in the blood and cerebrospinal fluid of patients with benign intracranial hypertension and raised intracranial pressure, patients with other neurological diseases and in normal control subjects. There was no difference in blood levels in each of the 3 groups (mean +/- SEM, 2.8 +/- 0.5, 2.5 +/- 0.25, 2.53 +/- 0.4 pg/ml). However, levels of arginine vasopressin in the cerebrospinal fluid in patients with benign intracranial hypertension and other neurological diseases were higher (mean +/- SEM, 0.64 +/- 0.005, 0.61 +/- 0.04 pg/ml), than in the control group (0.49 +/- 0.06), but not different from each other. The origin of arginine vasopressin in cerebrospinal fluid is uncertain and a number of possibilities are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097302     DOI: 10.1016/0022-510x(82)90190-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.

Authors:  J R Seckl; S L Lightman
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.

Authors:  J Seckl; S Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

3.  Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.

Authors:  J Sundquist; M L Forsling; J E Olsson; M Akerlund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

4.  Cerebrospinal fluid and plasma vasopressin during short-time induced intracranial hypertension.

Authors:  P S Sørensen; F Gjerris; M Hammer
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

5.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

6.  Neuroprotective effect of total glycosides from paeonies against neurotoxicity induced by strychnos alkaloids related to recovering the levels of neurotransmitters and neuroendocrine hormones in rat serum and brain.

Authors:  Linjia Sun; Yu Chen; Chenzhi Hou; Xiaoyang Sun; Zhipeng Wang; Shujuan Li; Mingming Lv; Xiaohui Chen
Journal:  RSC Adv       Date:  2018-08-16       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.